LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

NVS

147.88

+2.04%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

NVS

147.88

+2.04%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

NVS

147.88

+2.04%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

NVS

147.88

+2.04%↑

AZN

184.48

+1.46%↑

LLY

987.98

+2.24%↑

JNJ

224.37

+1.35%↑

ABBV

207.85

+2.48%↑

NVS

147.88

+2.04%↑

AZN

184.48

+1.46%↑

Inicio・Lista de Acciones・Cassava Sciences Inc

Cassava Sciences Inc

Cerrado

SectorSanidad

2.1

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.1

Máximo

2.1

Métricas clave
By Trading Economics
Ingresos	-1.7M -13M
Ventas	840K 840K
Margen de beneficios	-1,492.738
Empleados	30
EBITDA	-39M -50M

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-4.3M 142M
Apertura anterior	2.1
Cierre anterior	2.1

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

1.56 / 1.7 Soporte y Resistencia

Cassava Sciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

19 mar 2026, 18:34 UTC

Ganancias

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

19 mar 2026, 17:43 UTC

Principales Movimientos del Mercado

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

19 mar 2026, 23:47 UTC

Ganancias

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

19 mar 2026, 23:47 UTC

Ganancias

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

19 mar 2026, 23:47 UTC

Ganancias

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

19 mar 2026, 23:47 UTC

Ganancias

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

19 mar 2026, 23:39 UTC

Ganancias

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

19 mar 2026, 23:39 UTC

Ganancias

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

19 mar 2026, 23:39 UTC

Ganancias

Li Ning: Outdoor Category Continued Growing >2331.HK

19 mar 2026, 23:38 UTC

Ganancias

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

19 mar 2026, 23:33 UTC

Charlas de Mercado

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

19 mar 2026, 22:42 UTC

Adquisiciones, fusiones, absorciones

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

19 mar 2026, 22:42 UTC

Adquisiciones, fusiones, absorciones

McCormick Has a Market Value of Around $14.8B -- WSJ

19 mar 2026, 22:42 UTC

Adquisiciones, fusiones, absorciones

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

19 mar 2026, 22:42 UTC

Adquisiciones, fusiones, absorciones

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

19 mar 2026, 22:23 UTC

Charlas de Mercado

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

19 mar 2026, 22:09 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

19 mar 2026, 22:06 UTC

Charlas de Mercado

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

19 mar 2026, 22:04 UTC

Ganancias

Adquisiciones, fusiones, absorciones

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

19 mar 2026, 22:03 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Global Energy Roundup: Market Talk

19 mar 2026, 22:03 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

19 mar 2026, 21:51 UTC

Ganancias

Adquisiciones, fusiones, absorciones

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

19 mar 2026, 20:57 UTC

Noticias de Eventos Importantes

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

19 mar 2026, 20:50 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Basic Materials Roundup: Market Talk

19 mar 2026, 20:19 UTC

Noticias de Eventos Importantes

Brent Crude Retreats After Touching $119 -- WSJ

19 mar 2026, 19:49 UTC

Charlas de Mercado

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

19 mar 2026, 19:26 UTC

Noticias de Eventos Importantes

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

19 mar 2026, 19:10 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Natural Gas Rises in Volatile Trading -- Market Talk

19 mar 2026, 19:06 UTC

Noticias de Eventos Importantes

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

19 mar 2026, 18:08 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Silver Extends Slide to Seven Straight Sessions -- Market Talk

Comparación entre iguales

Cambio de precio

Cassava Sciences Inc previsión

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para Cassava Sciences Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.56 / 1.7Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Finanzas

Acerca de Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.